换一批
换一批Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.
第一作者：
Amin H,Nassar
第一单位：
Yale University School of Medicine, New Haven, Connecticut, USA.
作者：
Amin H,Nassar [1]
;
Sarah,Abou Alaiwi [1]
;
Talal,El Zarif [1]
;
Ryan,Denu [2]
;
Walid,Macaron [2]
;
Noha,Abdel-Wahab [2]
;
Dory,Freeman [3]
;
Alexi,Vasbinder [4]
;
Salim,Hayeck [4]
;
Elizabeth,Anderson [4]
;
Rachel S,Goodman [5]
;
Douglas B,Johnson [5]
;
Shirly,Grynberg [6]
;
Ronnie,Shapira [6]
;
Jennifer M,Kwan [1]
;
Rachel,Woodford [7]
;
Georgina V,Long [7]
;
Tarek,Haykal [8]
;
Susan,Dent [9]
;
Yuki,Kojima [10]
;
Kan,Yonemor [10]
;
Ankita,Tandon [11]
;
Alexandra,Trevino [12]
;
Nausheen,Akhter [12]
;
Eric H,Yang [13]
;
Gavin,Hui [14]
;
Alexandra,Drakaki [14]
;
Edward,El-Am [15]
;
Elie,Kozaily [15]
;
Ahmad,Al-Hader [15]
;
Elias,Bou Farhat [16]
;
Priyanka,Babu [1]
;
Arjun,Mittra [17]
;
Mingjia,Li [17]
;
Nicholas,Jones [17]
;
Javier,Baena [18]
;
Mercedes,Juarez Herrera [18]
;
Simone,Foderaro [19]
;
Frank Aboubakar,Nana [20]
;
Chul,Kim [21]
;
Paul,Sackstein [21]
;
Kaushal,Parikh [22]
;
Aakash P,Desai [22]
;
Caleb,Smith [22]
;
Alessio,Cortellini [23]
;
David J,Pinato [24]
;
James,Korolewicz [25]
;
Nerea,Lopetegui-Lia [26]
;
Pauline,Funchain [26]
;
Arrush,Choudhary [27]
;
Aarti,Asnani [27]
;
Vishal,Navani [28]
;
Daniel,Meyers [28]
;
Igor,Stukalin [28]
;
Jesus Antonio,Ocejo Gallegos [29]
;
Jonathan,Trent [29]
;
Sanober,Nusrat [30]
;
Carmel,Malvar [31]
;
Rana R,McKay [31]
;
Tomas G,Neilan [32]
;
Toni K,Choueiri [33]
;
Abdul Rafeh,Naqash [34]
作者单位：
Yale University School of Medicine, New Haven, Connecticut, USA.
[1]
Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
[2]
Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
[3]
Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
[4]
Department of Medicine, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, Nashville, Tennessee, USA.
[5]
Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Ramat Gan, Israel.
[6]
Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
[7]
Duke Cancer Institute, School of Medicine, Duke University, Durham, North Carolina, USA.;Department of Internal Medicine, Division of medical Oncology, The Ohio State University College of Medicine, Columbus, Ohio, USA.
[8]
Duke Cancer Institute, School of Medicine, Duke University, Durham, North Carolina, USA.
[9]
National Cancer Center Hospital, Tokyo, Japan.
[10]
Department of Medical Oncology, Loyola University Medical Center, Maywood, Illinois.
[11]
Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
[12]
UCLA Cardio-oncology Program, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
[13]
UCLA Cardio-oncology Program, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, California, USA.;Hematology/Oncology Department, David Geffen School of Medicine, Los Angeles, California, USA.
[14]
Department of Medicine, Indiana University School of Medicine Eskenazi Hospital, Indianapolis, Indiana, USA.
[15]
Brigham and Women's Hospital, Boston, Massachusetts, USA.
[16]
Division of Medical Oncology, The Ohio State University, Columbus, Ohio, USA.
[17]
Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.
[18]
Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
[19]
Division of Pneumology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
[20]
Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC, Washington, DC, USA.
[21]
Division of Medical Oncology, Mayo Clinic, Rochester, New York, USA.
[22]
Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.;Department of Medicine and Surgery, Universitá Campus Bio-Medico di Roma, Roma, Italy.;Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK.
[23]
Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK.;Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
[24]
Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK.
[25]
Department of Medical Oncology, Cleveland Clinic, Cleveland, Ohio, USA.
[26]
Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
[27]
Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.
[28]
Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
[29]
Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma, USA.
[30]
Moores Cancer Center, University of California San Diego, La Jolla, California, USA.
[31]
Cardio-Oncology Program, Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
[32]
Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA abdulrafeh-naqash@ouhsc.edu toni_choueiri@dfci.harvard.edu.
[33]
Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma, USA abdulrafeh-naqash@ouhsc.edu toni_choueiri@dfci.harvard.edu.
[34]
主题词
人类(Humans);回顾性研究(Retrospective Studies);男(雄)性(Male);女(雌)性(Female);老年人(Aged);中年人(Middle Aged);心脏肿瘤(Heart Neoplasms);治疗结果(Treatment Outcome)
DOI
10.1136/jitc-2024-009364
PMID
40032601
发布时间
2025-03-15
- 浏览1
Journal for immunotherapy of cancer
Journal for immunotherapy of cancer
2025年13卷3期
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
